Angiodynamic Profit Margin

The latest profit margin for ANGO is -11.48% as of May 2026. That compares with -11.62% in the prior-year period — up 1.3% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Angiodynamic's historical trend and sector peers before judging valuation or financial health.

Over the past year, ANGO's profit margin moved from -11.62% to -11.48% — a 1.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Angiodynamic's valuation or profitability profile.

Against Healthcare companies, ANGO currently prints -11.48% for profit margin, while the sector average sits near 13.89%. That is roughly 182.6% below the sector mean. Large gaps often invite a closer look at Angiodynamic's growth, margins, and balance sheet.

Profit Margin shows how effectively Angiodynamic converts resources into returns. At -11.48%, ANGO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -11.62% in the prior-year period — up 1.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ANGO's profit margin (-11.48%), review year-over-year change from -11.62%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.